Post navigation Zenocutuzumab Treatment Beyond Progression Demonstrates Continued Benefit in Patients with NRG1+ Non-Small Cell Lung Cancer: New Results from the eNRGy TrialIonis scraps early candidate for Alzheimer’s in people with Down syndrome